About Curist
Curist is a Healthcare company based in New York (United States) founded in 2018 by Ethan Lauf Goldstein. Generic drugs are manufactured by Curist in the pharmaceutical sector. Curist has raised $707.5 thousand across 1 funding round. Its chief executive, as recorded, is Ethan Lauf Goldstein. Its website curistrelief.com draws about 92 thousand monthly visits. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.
Company details
Curist was established in 2018 in New York, United States, as a manufacturer of generic drugs. Operations are centered on producing affordable pharmaceutical alternatives, with a focus on relief-oriented products accessible via the domain curistrelief.com. Leadership is provided by founder and CEO Ethan Lauf Goldstein. The company functions within the generics industry, serving markets through standard distribution channels in the U.S.
- Headquarters New York, United States
- Founders Ethan Lauf Goldstein
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website curistrelief.com
- Social LinkedIn X Facebook
- Total Equity Funding$707.5K (USD)
in 1 rounds
- Latest Funding Round$707.5K (USD), Seed
Sep 2019
Funding Insights of Curist
Curist has successfully raised a total of $707.5K through 1 strategic funding round. The most recent funding activity was a Seed round of $707.5 thousand completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $707,500
- Total Rounds 1
- Last Round Seed — $707,500
- First Round $707,500
(Sep 2019)
All 1 funding rounds of Curist with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2019 | $707,500 | Seed | – | – | – |
People of Curist
1 people are tracked at Curist (1 in leadership).
| Name | Role | Group |
|---|---|---|
Ethan Lauf Goldstein | Founder & CEO | Leadership |
Complete people profiles for Curist
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Curist
2 dated milestones of Curist across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Curist is founded.
- Funding First funding round of $708K.
Web traffic of Curist
The website of Curist (curistrelief.com) receives about 92.4K visits a month.
- Monthly visits92.4K
▼ 5.7% vs previous month
Websites whose visitors overlap most with Curist. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| mdacne.com | 99% | 185.9K | #188,124 | View details | |
| enclarapharmacia.com | 82% | 27.9K | #911,512 | View details | |
| allegra.com | 48% | 244.2K | #202,571 | View details |
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Curist (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Curist
Curist was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Curist is headquartered in New York, United States. It is registered at New York, New York, United States.
Ethan Lauf Goldstein is the CEO of Curist, as recorded in our data. They have also founded this company.
Curist is a funded company, having raised a total of $707.5K across 1 funding round to date. The company's 1st funding round was a Seed of $707.5K, raised on Sep 2019.
Curist was established in 2018 in New York, United States, as a manufacturer of generic drugs. Operations are centered on producing affordable pharmaceutical alternatives, with a focus on relief-oriented products accessible via the domain curistrelief.com. Leadership is provided by founder and CEO Ethan Lauf Goldstein. The company functions within the generics industry, serving markets through standard distribution channels in the U.S.